2018 Annual Meeting | C194 - Actualización Sobre el Manejo del Ictus Cerebrovascular

Date Thursday 04/26/18

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Carlos S. Kase, MD, FAHA, FAAN

Topic(s)

Learning Objectives Al completar el programa, los participantes debieran estar al día en los aspectos básicos de la terapia del ictus isquémico y hemorrágico, incluyendo la última información relacionada con el manejo neuro-intervencionista del ictus isquémico agudo, opciones para el tratamiento del ictus relacionado a la presencia de un foramen oval permeable, y manejo de la presión arterial en la etapa inicial del ictus hemorrágico intraparenquimatoso.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills

Program Tracks Neurohospitalist, Spanish Language

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
01:00 PM - 01:05 PM	Speaker	Introducción Carlos S. Kase, MD, FAHA, FAAN
01:05 PM - 01:50 PM	Speaker	Actualización en Ictus Isquémico Jose G. Romano, MD, FAAN
01:50 PM - 02:35 PM	Speaker	Actualización en Ictus Hemorrágico Carlos S. Kase, MD, FAHA, FAAN
02:35 PM - 02:55 PM	Speaker	Discusión de Casos Clínicos Enrique C. Leira, MD, MS, FAAN
02:55 PM - 03:00 PM	Closing Remarks	Conclusión Carlos S. Kase, MD, FAHA, FAAN

Faculty Disclosures
Carlos S. Kase, MD, FAHA, FAAN	Dr. Kase has nothing to disclose.
Enrique C. Leira, MD, MS, FAAN	Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS.
Jose G. Romano, MD, FAAN	Dr. Romano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Romano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vycor. Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NIMHHD.